Lucy Scientific Discovery Reiterates Its Proposal to Acquire Pasithea Therapeutics
Lucy Scientific Discovery Reiterates Its Proposal to Acquire Pasithea Therapeutics
露西科學發現重申其收購 Pasithea Therapeutics 的提議
Under the terms of the offer made on June 5th, Lucy proposed to pay $0.60 in cash, and $0.25 cents in Lucy stock (NASDAQ:LSDI) for every share of Pasithea common stock. Given that Pasithea's stock closed at $0.35 per share on June 1, 2023, the Proposal of $0.85 per share equates to 142% premium to Pasithea's share price. In fact, the cash component alone represents a 71% premium.
根據6月5日提出的要約條款，露西提議爲每股Pasithea普通股支付0.60美元的現金和0.25美分的露西股票（納斯達克股票代碼：LSDI）。鑑於Pasithea的股票於2023年6月1日收於每股0.35美元，每股0.85美元的提案相當於Pasithea的股價溢價142％。實際上，僅現金部分就代表了71％的溢價。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。